BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17880623)

  • 21. Evaluation of a new apheresis system for the collection of leukoreduced single-donor platelets.
    Zingsem J; Strasser E; Ringwald J; Zimmermann R; Weisbach V; Eckstein R
    Transfusion; 2007 Jun; 47(6):987-94. PubMed ID: 17524087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantity, quality, and functionality of peripheral blood cells derived from residual blood of different apheresis kits.
    Knörck A; Marx S; Friedmann KS; Zöphel S; Lieblang L; Hässig C; Müller I; Pilch J; Sester U; Hoth M; Eichler H; Sester M; Schwarz EC
    Transfusion; 2018 Jun; 58(6):1516-1526. PubMed ID: 29732580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative assessment of single-donor plateletpheresis by Haemonetics
    Baruah S; Bajpai M
    Asian J Transfus Sci; 2020; 14(1):23-27. PubMed ID: 33162701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Removal of Plasmodium falciparum-infected red blood cells from whole blood by leukoreduction filters.
    Cardo LJ; Salata J; Wilder D
    Transfusion; 2009 Feb; 49(2):337-46. PubMed ID: 19389214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on leucodepletion, HLA and platelet serology at Lisbon Regional Blood Centre.
    de Sousa G
    Transfus Apher Sci; 2003 Aug; 29(1):5-10. PubMed ID: 12877885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White cell content in apheresis platelets.
    Burgstaler EA; Pineda AA
    Transfusion; 1993; 33(11):960-1. PubMed ID: 8259601
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of Plasma Products for Cellular Contaminants: Comparing Standard Preparation Methods.
    Rieske RR; Kutcher ME; Audia JP; Carter KT; Lee YL; Tan YB; Gillespie MN; Capley GC; Tatum DM; Smith AA; Duchesne JC; Simmons JD
    J Am Coll Surg; 2020 Apr; 230(4):596-602. PubMed ID: 32220451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).
    Dohan Ehrenfest DM; Rasmusson L; Albrektsson T
    Trends Biotechnol; 2009 Mar; 27(3):158-67. PubMed ID: 19187989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukocyte depletion for safe blood transfusion.
    Singh S; Kumar A
    Biotechnol J; 2009 Aug; 4(8):1140-51. PubMed ID: 19418471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukoreduction of transfused blood and postoperative infection: the "confounder variable" hypothesis.
    Pereira A
    Transfusion; 2007 Oct; 47(10):1945-6; author reply 1947-8. PubMed ID: 17880625
    [No Abstract]   [Full Text] [Related]  

  • 31. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.
    Wagner SJ; Vassallo R; Skripchenko A; Einarson M; Seetharaman S; Moroff G
    Transfusion; 2008 Jun; 48(6):1072-80. PubMed ID: 18373503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated collection of double red blood cell units with a variable-volume separation chamber.
    Aubuchon JP; Dumont LJ; Herschel L; Roger J; Beddard RL; Taylor HL; Whitley PH; Sawyer SL; Graminske S; Martinson K; Dora R; Heldke S; Adamson J; Rose LE
    Transfusion; 2008 Jan; 48(1):147-52. PubMed ID: 17894787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis.
    Procházková R; Andrýs C; Hubácková L; Krejsek J
    Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on multi-center clinical trials in the United States.
    Afenyi-Annan A; Brecher ME; Bandarenko N
    Transfus Apher Sci; 2007 Feb; 36(1):5-12. PubMed ID: 17276142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stored platelet concentrates produced by the platelet-rich plasma method are more resistant to apoptosis but more sensitive to activation than are platelets prepared by the buffy-coat and apheresis methods.
    Leytin V; Allen DJ; Mutlu A; Mykhaylov S; Lyubimov E; Freedman J
    Transfusion; 2009 Jul; 49(7):1493-4. PubMed ID: 19602211
    [No Abstract]   [Full Text] [Related]  

  • 36. Preparation of highly concentrated and white cell-poor platelet-rich plasma by plateletpheresis.
    Zimmermann R; Reske S; Metzler P; Schlegel A; Ringwald J; Eckstein R
    Vox Sang; 2008 Jul; 95(1):20-5. PubMed ID: 18444946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet contamination causes large variation as well as overestimation of mitochondrial DNA content of peripheral blood mononuclear cells.
    Urata M; Koga-Wada Y; Kayamori Y; Kang D
    Ann Clin Biochem; 2008 Sep; 45(Pt 5):513-4. PubMed ID: 18753426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A; Kurtz J; Moroff G; Wagner SJ
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Joint meeting of the Interdisciplinary European Society for Haemapheresis and Haemotherapy (ESFH) and the Société Fran aise d’Hémaphérèse.
    Moog R
    Transfus Apher Sci; 2010 Oct; 43(2):199. PubMed ID: 20667789
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical analysis of dendritic cell subsets: the dendritogram.
    Hosmalin A; Lichtner M; Louis S
    Methods Mol Biol; 2008; 415():273-90. PubMed ID: 18370160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.